Ultragenyx Pharmaceutical Inc.: Form 8-K, filed Mar 12, 2026
Filed with the SEC on Mar 12, 2026 and accepted by EDGAR at Mar 12, 2026, 08:45 ET.
Items reported
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-103167. Last ingested by Listed: Nov 14, 2026, 11:37 ET. Listed shows no prices and gives no investment advice.